Novartis (NOT) – cijena dionice i vijesti

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia

Novartis – informacije

Glavni izvršni direktorVasant Narasimhan

Zaposlenici75,3 tis.

Osnovano7. ožu 1996.

SjedišteBasel, Basel-grad, Švicarska

Sektor-

Web-lokacijanovartis.com

Sve vrijednosti su u valuti USD	ruj 2025.	pro 2025.	ožu 2026.	lip 2026.
Prihod	14,36 mlr.	13,86 mlr.	13,52 mlr.	14,95 mlr.
Trošak prodane robe	3,54 mlr.	3,54 mlr.	3,44 mlr.	3,68 mlr.
Trošak prihoda	3,54 mlr.	3,54 mlr.	3,44 mlr.	3,68 mlr.
Izdaci za istraživanje i razvoj	2,86 mlr.	2,84 mlr.	2,78 mlr.	2,74 mlr.
Ukupni izdaci za istraživanje i razvoj	-	-	-	-
Izdaci za prodaju, opći i administrativni izdaci	3,30 mlr.	3,44 mlr.	3,14 mlr.	3,23 mlr.
Poslovni rashod	6,24 mlr.	6,46 mlr.	5,96 mlr.	6,10 mlr.
Ukupni poslovni rashodi	9,77 mlr.	10,00 mlr.	9,40 mlr.	9,78 mlr.
Poslovni prihod	4,58 mlr.	3,86 mlr.	4,12 mlr.	5,18 mlr.
Ostali neposlovni prihod	−7,00 mil.	−130,00 mil.	4,00 mil.	19,00 mil.
Zarada prije poreza uključujući neuobičajene stavke	4,20 mlr.	3,22 mlr.	3,84 mlr.	4,27 mlr.
Zarada prije poreza isključujući neuobičajene stavke	4,29 mlr.	3,49 mlr.	3,78 mlr.	4,73 mlr.
Izdaci za porez na dohodak	266,00 mil.	814,00 mil.	683,00 mil.	1,01 mlr.
Efektivna porezna stopa	6,34 %	25,30 %	17,79 %	23,71 %
Ostali poslovni rashodi	70,00 mil.	190,00 mil.	42,00 mil.	127,00 mil.
Neto dohodak	3,93 mlr.	2,41 mlr.	3,16 mlr.	3,26 mlr.
Neto profitna marža	27,36 %	17,38 %	23,34 %	21,83 %
Zarada po dionici	2,25	2,03	1,99	2,41
Prihod od kamata i ulaganja	-	373,00 mil.	-	-
Izdaci za kamate	−281,00 mil.	−304,00 mil.	−343,00 mil.	−462,00 mil.
Neto izdaci za kamate	−281,00 mil.	69,00 mil.	−343,00 mil.	−462,00 mil.
Troškovi amortizacije i otpisa	-	-	-	-
Dobit prije kamata, poreza i amortizacije	5,78 mlr.	4,96 mlr.	5,24 mlr.	6,30 mlr.
Dobit ili gubitak od prodaje imovine	81,00 mil.	80,00 mil.	−159,00 mil.	−247,00 mil.

Pitajte bilo što